Your De-Identified DNA Can Identify You....
Genetic testing is here, is not going to get less common and we will all have our DNA mapped by 2020....but I could be wrong - it could be 2018. However, when ...
Two Years of Adjuvant Therapy for Patients with Her2+ Cancer, Do I Hear Three?
Neratinib (oral tyrosine kinase inhibitor - dual blockade of HER2 and EGFR kinases) for 1 year AFTER neo/adjuvant chemo/trastuzumab - so 2 years total of therap...
CRISPR Slowly Advances into the Clinic
An article by Susan Jenks appears in a recent edition of the Journal of the National Cancer Institute (JNCI 2017;109 (10)) The articled is titled “CRISPR Slowly...
New SERM, New era??
A new SERM - Z-Endoxifen has shown promise in a phase 1 study of 38 pts. Stable disease >6m or partial responses were seen in 26% of patients and the maximum t...
Disruptive Technology Alert: FDA-cleared Smartphone Ultrasound
A high quality, all-body, smartphone-based, PACS-compatible ultrasound probe for $2,ooo. This particular tech development may soon appear in the dictionary unde...
From the Forum: Not Risk Factors for Lymphedema: Blood draws, IVs, BPs, Exercise, Air travel
Risk factors for Lymphedema: High BMI, Axillary dissection, Chemotherapy (esp taxanes), Radiation, Infection Not Risk Factors for Lymphedema: blood draws, IVs, ...
Cureus Competition Winner Announced!
In 2016, Cureus and TME sponsored a case report research competition called: Exceptional Responders in Breast cancer. We sought challenging cases where breast c...
Blood Test for Diagnosing Cancer #HolyGrail
Researchers at Johns Hopkins and their spin off company Personal Genome Diagnostics published a paper on their preliminary study of 138 early stage cancer patie...
Why John West M.D. is Passionate about Starting Mammography at "40not50"
BreastCareNetwork interviewed Breastlink founder Dr. John West about controversial breast screening guidelines and his ambitious new book aimed at providing all...
